Fig. 6From: mRNA nanodelivery systems: targeting strategies and administration routesSchematic illustration of the structure of the liver and the journey of mRNA NPs to all kinds of cells in the liver via intravenous injection. The passive and active targeting characteristics of hepatocytes, hepatic stellate cells and hepatic endothelial cells are also presentedBack to article page